Andries M. Bergman

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Urology, Oncology, Docetaxel Chemotherapy +9

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Godefridus J. Peters, Andries M. Bergman, V W Ruiz van Haperen et al. · PubMed · 1995 · 314 citations

Synergistic interaction between cisplatin and gemcitabine in vitro.

Andries M. Bergman, V W Ruiz van Haperen, G. Veerman et al. · PubMed · 1996 · 306 citations

Chemoprevention Strategy, Medicine, Pharmacology +13

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu et al. · Nature Genetics · 2020 · 271 citations · Full text

Developmental Biology, Epigenomics, Cancer Genomics +3

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg et al. · Journal of Clinical Oncology · 2016 · 244 citations